Hormone Therapy and Risk of Breast Cancer: Where Are We Now?

John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein
{"title":"Hormone Therapy and Risk of Breast Cancer: Where Are We Now?","authors":"John P Micha,&nbsp;Mark A Rettenmaier,&nbsp;Randy D Bohart,&nbsp;Bram H Goldstein","doi":"10.6118/jmm.21035","DOIUrl":null,"url":null,"abstract":"<p><p>Several studies have examined the clinical benefits of hormone replacement therapy (HRT). However, because long-term use of HRT has been implicated as a risk factor for the development of breast cancer, some women remain skeptical when considering this therapy to address their vasomotor symptoms. Hence, physicians and nurses should actively engage in constructive discourse with their patients regarding HRT while specifically reviewing the potential risks of its extended use as well as provide the available medical alternatives the patients could potentially use.</p>","PeriodicalId":16410,"journal":{"name":"Journal of Menopausal Medicine","volume":"28 2","pages":"47-51"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/44/jmm-28-47.PMC9452594.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Menopausal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6118/jmm.21035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Several studies have examined the clinical benefits of hormone replacement therapy (HRT). However, because long-term use of HRT has been implicated as a risk factor for the development of breast cancer, some women remain skeptical when considering this therapy to address their vasomotor symptoms. Hence, physicians and nurses should actively engage in constructive discourse with their patients regarding HRT while specifically reviewing the potential risks of its extended use as well as provide the available medical alternatives the patients could potentially use.

Abstract Image

激素治疗和乳腺癌的风险:我们现在在哪里?
一些研究已经检验了激素替代疗法(HRT)的临床益处。然而,由于长期使用激素替代疗法被认为是乳腺癌发展的一个危险因素,一些妇女在考虑使用这种疗法来解决她们的血管舒缩症状时仍然持怀疑态度。因此,医生和护士应该积极地与患者就激素替代疗法进行建设性的讨论,同时特别审查其长期使用的潜在风险,并提供患者可能使用的可用医疗替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信